Biotech

All Articles

Enanta's RSV antiviral crushes virus-like load in obstacle research study

.Enanta Pharmaceuticals has actually linked its breathing syncytial virus (RSV) antiviral to signifi...

Biogen cans SAGE-324 cooperation after necessary trembling fail

.Biogen has carried out the final rites to its cooperation along with Sage Therapies on SAGE-324, di...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel acquistion scores

.On the very same time that some Parkinson's ailment drugs are actually being actually questioned, A...

Arch finalizes $3B-plus fund to cultivate biopharma startups

.On the heels of a $3 billion fund from Bain Financing Life Sciences, Arch Endeavor Partners is conf...

Orion to utilize Aitia's 'electronic twins' to discover new cancer medications

.Finnish biotech Orion has spied possible in Aitia's "digital double" specialist to build brand new ...

Windtree's surprise med increases blood pressure in most current phase 2 win

.While Windtree Therapies has battled to develop the financial origins needed to endure, a phase 2 g...

2 cancer cells biotechs merge, making global footprint

.OncoC4 is taking AcroImmune-- as well as its own internal clinical production functionalities-- und...

Amgen reports 1st stage 3 win for $400M eczema medicine

.Amgen has actually discussed (PDF) the very first stage 3 data on its $400 million eczema drug, lin...

Biogen, UCB document stage 3 lupus win after failing earlier trial

.Biogen and also UCB's rely on developing right into phase 3 on the back of an unsuccessful research...

Aptadir wishes brand new RNA preventions may reverse difficult cancers

.Italian biotech Aptadir Therapeutics has released with the commitment that its pipeline of preclini...